Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and seronegative spondyloarthropathies, can be treated with the help of these drugs.
The report details the trend, potential and market size of Tumor Necrosis Factor Alpha Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Necrosis Factor Alpha Inhibitorsmarket, defines the market attractiveness level of Tumor Necrosis Factor Alpha Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tumor Necrosis Factor Alpha Inhibitors industry, describes the types of Tumor Necrosis Factor Alpha Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Necrosis Factor Alpha Inhibitors market and the development prospects and opportunities of Tumor Necrosis Factor Alpha Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Necrosis Factor Alpha Inhibitors market in Chapter 13.
By Player:
Sanofi
Zydus Cadila
Novartis
Momenta Pharmaceuticals
LG Life Sciences
AbbVie
Janssen Biotech
AstraZeneca
AryoGen Pharmed
HanAll Biopharma
GlaxoSmithKline
By Type:
Humira
Enbrel
Remicade
Others
By End-User:
Medicine
Scientific Research
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tumor Necrosis Factor Alpha Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tumor Necrosis Factor Alpha Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tumor Necrosis Factor Alpha Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tumor Necrosis Factor Alpha Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tumor Necrosis Factor Alpha Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.2 United States Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.3 Europe Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.4 China Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.5 Japan Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.6 India Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
-
7.7 South Korea Tumor Necrosis Factor Alpha Inhibitors Consumption (2017-2022)
8 Region and Country-wise Tumor Necrosis Factor Alpha Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast (2022-2028)
9 Global Tumor Necrosis Factor Alpha Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medicine Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tumor Necrosis Factor Alpha Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medicine Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tumor Necrosis Factor Alpha Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tumor Necrosis Factor Alpha Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tumor Necrosis Factor Alpha Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tumor Necrosis Factor Alpha Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tumor Necrosis Factor Alpha Inhibitors Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.2 Zydus Cadila
-
14.2.1 Zydus Cadila Company Details
-
14.2.2 Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.4 Momenta Pharmaceuticals
-
14.4.1 Momenta Pharmaceuticals Company Details
-
14.4.2 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.5 LG Life Sciences
-
14.5.1 LG Life Sciences Company Details
-
14.5.2 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.7 Janssen Biotech
-
14.7.1 Janssen Biotech Company Details
-
14.7.2 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.9 AryoGen Pharmed
-
14.9.1 AryoGen Pharmed Company Details
-
14.9.2 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.10 HanAll Biopharma
-
14.10.1 HanAll Biopharma Company Details
-
14.10.2 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
14.11 GlaxoSmithKline
-
14.11.1 GlaxoSmithKline Company Details
-
14.11.2 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tumor Necrosis Factor Alpha Inhibitors
-
Figure Tumor Necrosis Factor Alpha Inhibitors Picture
-
Table Global Tumor Necrosis Factor Alpha Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor Alpha Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tumor Necrosis Factor Alpha Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tumor Necrosis Factor Alpha Inhibitors Consumption by Country (2017-2022)
-
Figure United States Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tumor Necrosis Factor Alpha Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tumor Necrosis Factor Alpha Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Scientific Research Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tumor Necrosis Factor Alpha Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tumor Necrosis Factor Alpha Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table Momenta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table LG Life Sciences (Foundation Year, Company Profile and etc.)
-
Table LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table AryoGen Pharmed (Foundation Year, Company Profile and etc.)
-
Table AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table HanAll Biopharma (Foundation Year, Company Profile and etc.)
-
Table HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Product and Service
-
